XT
IMRX icon

XTX Topco’s Immuneering IMRX Stock Holding History

XTX Topco’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
+64,395
New +$326K ﹤0.01% 2857
2025
Q4 		– Sell
-64,040
Closed -$448K – 3536
2025
Q3 		$448K Buy
64,040
+37,211
+139% +$193K 0.02% 1156
2025
Q2 		$90.4K Buy
+26,829
New +$46K ﹤0.01% 1902
2025
Q1 		– Sell
-32,650
Closed -$71.8K – 2710
2024
Q4 		$71.8K Buy
32,650
+20,871
+177% +$43.3K 0.01% 1833
2024
Q3 		$29.3K Sell
11,779
-22,380
-66% -$32.5K ﹤0.01% 1781
2024
Q2 		$43.7K Buy
34,159
+9,274
+37% +$15.2K ﹤0.01% 1524
2024
Q1 		$71.9K Buy
+24,885
New +$139K 0.01% 1411

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

XTX Topco's IMRX Position: Q2 2026 in Review

XTX Topco opened a new position in Immuneering (IMRX) in Q2 2026: 64,395 shares worth $321K. The stake represents ﹤0.01% of the portfolio and ranks #2857 among its holdings. This is a return to the name: XTX Topco previously reported a position in IMRX as recently as Q3 2025.

XTX Topco first reported a position in IMRX in Q1 2024 and has held it in 7 quarters since. The position peaked at $448K in Q3 2025. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • XTX Topco held 64,395 shares of Immuneering worth $321K as of Q2 2026.
  • Immuneering was a new XTX Topco position in Q2 2026.
  • Immuneering made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2857 holding.
  • XTX Topco first reported a position in Immuneering in Q1 2024 and has held it in 7 quarters since.
  • XTX Topco's Immuneering position peaked at $448K in Q3 2025.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.